Cart summary

You have no items in your shopping cart.

Reference Antibodies

 

Reference Antibodies

 

What are reference antibodies?

Reference antibodies are standardized antibodies that allow for comparison between antibodies. Reference antibodies are a vital component in research, diagnostics, and the development of effective therapeutic agents.

  • They can be used as a standard to allow for the comparison of results from different experiments.
  • They can be used as a standard to evaluate and validate new protocols.
  • They allow for the reproducibility of experiments.
  • They can be used to evaluate the efficacy of new drugs and treatments.

Biorbyt offers reference antibodies for a diversity of research fields. Below are some of our featured antibodies.

Anti-TNFSF2 / TNFa Reference Antibody (adalimumab)

TNF-A, Tumor Necrosis Factor Alpha, is a cytokine secreted by the immune system and involved with inflammation. It is often used in cancer research, as it can cause cell death in particular cancer lines.

Anti-TNFSF2 / TNFa Reference Antibody (adalimumab)

Anti-IL-5 Reference Antibody (mepolizumab)

IL-5 is a cytokine that plays an important role in eosinophils, inflammatory cells linked to asthma.

Anti-IL-5 Reference Antibody (mepolizumab)

Anti-CD20 Reference Antibody (rituximab)

CD20 is a membrane protein on B lymphocytes that regulates calcium influx. CD20 is associated with rheumatoid arthritis and other autoimmune diseases.

Anti-CD20 Reference Antibody (rituximab)

Anti-ERBB1 / EGFR / HER1 Reference Antibody (cetuximab)

EGF, epidermal growth factor, is a signaling protein that regulates cell growth and proliferation. Antibodies are used in cancer research to prevent proliferation of tumors.

Anti-ERBB1 / EGFR / HER1 Reference Antibody (cetuximab)

Anti-CD52 Reference Antibody (alemtuzumab)

CD52 is a protein that plays an important role in lymphocytes. Antibodies are used to study multiple conditions, particularly leukemia and multiple sclerosis.

Anti-CD52 Reference Antibody (alemtuzumab)

Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)

IL-6 is a protein involved in inflammation and immune response. IL-6RA antibodies prevent binding to the receptor and restrict IL-6 activity.

Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)

Anti-Siglec-3 / CD33 Reference Antibody (Gemtuzumab)

Is a cell surface receptor on myeloid cells. Antibodies are used in cancer research for leukemia.

Anti-Siglec-3 / CD33 Reference Antibody (Gemtuzumab)